Latest On-Demand Webinars & Online Events

This online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organs-on-chips and key modeling strategies, as well as how research advances are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

Asset Management has traditionally been built for large pharma companies. But with advancements in technology, that is no longer true. Asset management programs are available for all companies, regardless of size.

Most organizations now recognize digitalization as a necessity for the lab of the future, yet many find it difficult to justify the expense, get stakeholder buy-in, or move the process forward. The delay carries significant risks – anything from untraceable data, lost protocols, to non-compliance of regulatory requirements on data integrity. It also takes away the opportunities to automate, scale up, and integrate lab processes efficiently.

In today’s world, laboratories are constantly pushed to be faster, more effective, more accurate, with less waste and cost. At the same time emerging technologies provide labs with an opportunity to change the way they work today making them more efficient and effective. Leveraging these technologies will determine the success of your lab to evolve into the lab of tomorrow.

Labs today face increasing demands from stakeholders, customers and suppliers, whether it’s improving efficiency, meeting regulatory compliance, increasing productivity or delivering high quality products to market faster. Technology has always played a vital role in the lab and knowing how to leverage that is at the core of digital transformation.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.

Now in its second year, this online symposium will provide those working within academia and pharmaceutical development the opportunity to hear from experts within the field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology

Point-of-care testing is the future of diagnostic solutions. The main reason for this is point-of-care testing is robust, easy to use and provides immediate results and thus allows treatment decisions to be made more quickly. As an additional benefit, point-of-care diagnostic testing brings value to patients and healthcare systems.

We are here to help progress point-of-care diagnostics with our glycerol-free enzymes. Lyo-ready enzymes are as efficient and as high in performance as traditional formats of enzymes and this new formulation is suitable for use in microfluidics instruments.

In this webinar, we will explore how retinal organoids are used as a platform to assess the safety and efficacy of retinal gene therapy treatments.